Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed; no other content changes.
    Difference
    0.3%
    Check dated 2025-09-14T18:59:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T14:32:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details while also revising the resources related to genetic and rare diseases, specifically focusing on various types of leukemia. The previous version's resources have been significantly reduced.
    Difference
    8%
    Check dated 2025-08-31T11:44:08.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    2%
    Check dated 2025-08-24T07:40:26.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    2%
    Check dated 2025-08-17T01:50:47.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    2%
    Check dated 2025-08-10T00:09:46.000Z thumbnail image

Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.